Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 4/20 | 0.60 |
| ▸ | CES1 | P23141 | 4/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11673566 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL3051705 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL15941224 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL1914743 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11673555 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL23437862 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11672548 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL7760601 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11673647 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11509036 | 0.97 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110845987-A | High-performance copolyamide hot melt adhesive composition | 南通协鑫热熔胶有限公司 | 2020-02-28 | — | — | CN | claimed |
| WO-2024071051-A1 | CURABLE COMPOSITION | 株式会社カネカ | 2024-04-04 | — | — | WO | disclosed |
| CN-117801001-A | MyL-1 compound for myelin marks in central nervous system, and preparation method and application thereof | 四川大学华西厦门医院(四川大学华西医学厦门研究院) | 2024-04-02 | — | — | CN | disclosed |
| CN-114728275-B | Curing catalyst for curing polymer, moisture-curable composition, and method for producing cured product | 日东化成株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-114729155-B | Moisture-curable composition and method for producing cured product | 日东化成株式会社 | 2024-02-13 | — | — | CN | disclosed |
| WO-2024029615-A1 | CURABLE COMPOSITION | 株式会社カネカ | 2024-02-08 | — | — | WO | disclosed |
| US-20230357509-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| WO-2023180126-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | LABORATOIRES M&L (FR) | 2023-09-28 | — | — | WO | disclosed |
| US-20230257487-A1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOSITURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| WO-2001000578-A1 | 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF | MERCK & CO., INC. (US) | 2001-01-04 | — | — | WO | disclosed |
| EP-0901489-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | Merck & Co., Inc. (US) | 1999-03-17 | — | — | EP | disclosed |
| US-5808165-A | CLAISEN CONDENSATION | RHONE-POULENC CHIMIE (FR) | 1998-09-15 | — | — | US | disclosed |
| US-5789138-A | Optical recording medium and method of producing the same | RICOH COMPANY, LTD. (JP) | 1998-08-04 | — | — | US | disclosed |
| WO-1997044339-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO., INC. (US) | 1997-11-27 | — | — | WO | disclosed |
| US-5475145-A | Odorless, nontoxic liquid mixtures for stabilizing polyvinyl chloride and other halopolymers | RHONE-POULENC (FR) | 1995-12-12 | — | — | US | disclosed |
| EP-0596809-A1 | Beta-diketones, process for their preparation and their use as polymer stabilizers | RHONE-POULENC CHIMIE (FR) | 1994-05-11 | — | — | EP | disclosed |
| US-4051229-A | REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST | THE JAPAN CARLIT CO., LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
| US-4036605-A | CATALYZING OXIDATION OF HYDROCARBONS WITH A B-KETOENOLATE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1977-07-19 | — | — | US | disclosed |
| US-3933837-A | 3,4-Methylenedioxyphenoxy-alkyl diketones and keto-esters | STERLING DRUG INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | HAO1 483/4885KMT2A 150/4885MAPT 2607/4885 |
| US-20230357509-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | HAO1 783/4885KMT2A 141/4885MAPT 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.